Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Nature. 2022 Aug;608(7923):609-617. doi: 10.1038/s41586-022-05066-5. Epub 2022 Aug 10.
Nature. 2022.
PMID: 35948633
Free PMC article.
Clinical Trial.
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Zingg D, Bhin J, Yemelyanenko J, Kas SM, Rolfs F, Lutz C, Lee JK, Klarenbeek S, Silverman IM, Annunziato S, Chan CS, Piersma SR, Eijkman T, Badoux M, Gogola E, Siteur B, Sprengers J, de Klein B, de Goeij-de Haas RR, Riedlinger GM, Ke H, Madison R, Drenth AP, van der Burg E, Schut E, Henneman L, van Miltenburg MH, Proost N, Zhen H, Wientjens E, de Bruijn R, de Ruiter JR, Boon U, de Korte-Grimmerink R, van Gerwen B, Féliz L, Abou-Alfa GK, Ross JS, van de Ven M, Rottenberg S, Cuppen E, Chessex AV, Ali SM, Burn TC, Jimenez CR, Ganesan S, Wessels LFA, Jonkers J.
Zingg D, et al. Among authors: van gerwen b.
Nature. 2022 Sep;609(7929):E13. doi: 10.1038/s41586-022-05287-8.
Nature. 2022.
PMID: 36050473
Free PMC article.
No abstract available.
Item in Clipboard
Degree and site of chromosomal instability define its oncogenic potential.
Hoevenaar WHM, Janssen A, Quirindongo AI, Ma H, Klaasen SJ, Teixeira A, van Gerwen B, Lansu N, Morsink FHM, Offerhaus GJA, Medema RH, Kops GJPL, Jelluma N.
Hoevenaar WHM, et al. Among authors: van gerwen b.
Nat Commun. 2020 Mar 20;11(1):1501. doi: 10.1038/s41467-020-15279-9.
Nat Commun. 2020.
PMID: 32198375
Free PMC article.
Item in Clipboard
Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.
Wojciechowicz K, Cantelli E, Van Gerwen B, Plug M, Van Der Wal A, Delzenne-Goette E, Song JY, De Vries S, Dekker M, Te Riele H.
Wojciechowicz K, et al. Among authors: van gerwen b.
Gastroenterology. 2014 Nov;147(5):1064-72.e5. doi: 10.1053/j.gastro.2014.07.052. Epub 2014 Jul 31.
Gastroenterology. 2014.
PMID: 25088490
Item in Clipboard
In situ CRISPR-Cas9 base editing for the development of genetically engineered mouse models of breast cancer.
Annunziato S, Lutz C, Henneman L, Bhin J, Wong K, Siteur B, van Gerwen B, de Korte-Grimmerink R, Zafra MP, Schatoff EM, Drenth AP, van der Burg E, Eijkman T, Mukherjee S, Boroviak K, Wessels LF, van de Ven M, Huijbers IJ, Adams DJ, Dow LE, Jonkers J.
Annunziato S, et al. Among authors: van gerwen b.
EMBO J. 2020 Mar 2;39(5):e102169. doi: 10.15252/embj.2019102169. Epub 2020 Jan 13.
EMBO J. 2020.
PMID: 31930530
Free PMC article.
Item in Clipboard
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer.
Annunziato S, de Ruiter JR, Henneman L, Brambillasca CS, Lutz C, Vaillant F, Ferrante F, Drenth AP, van der Burg E, Siteur B, van Gerwen B, de Bruijn R, van Miltenburg MH, Huijbers IJ, van de Ven M, Visvader JE, Lindeman GJ, Wessels LFA, Jonkers J.
Annunziato S, et al. Among authors: van gerwen b.
Nat Commun. 2019 Jan 23;10(1):397. doi: 10.1038/s41467-019-08301-2.
Nat Commun. 2019.
PMID: 30674894
Free PMC article.
Item in Clipboard
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland.
Annunziato S, Kas SM, Nethe M, Yücel H, Del Bravo J, Pritchard C, Bin Ali R, van Gerwen B, Siteur B, Drenth AP, Schut E, van de Ven M, Boelens MC, Klarenbeek S, Huijbers IJ, van Miltenburg MH, Jonkers J.
Annunziato S, et al. Among authors: van gerwen b.
Genes Dev. 2016 Jun 15;30(12):1470-80. doi: 10.1101/gad.279190.116.
Genes Dev. 2016.
PMID: 27340177
Free PMC article.
Item in Clipboard
Cite
Cite